Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly.

Author: IinoTomoharu, KanazuShinichi, KawakamiKenji, KishinoHiroyuki, MuseyLuwy, SawataMiyuki, TakahashiKenichi

Paper Details 
Original Abstract of the Article :
In the previous study, revaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in a total of 161 elderly subjects (≥70 years of age) who had received the initial vaccination at least 5 years before (range: 5 to11 years) showed an acceptable safety profile and induction of immune re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149784/

データ提供:米国国立医学図書館(NLM)

Pneumococcal Vaccination: A Shield Against the Desert Storms

Pneumococcal disease, a serious threat, is like a desert storm, capable of causing significant illness and even death. Vaccination, a critical tool for protecting against infectious diseases, is like a shield against the desert's harsh elements. Researchers are constantly seeking to optimize vaccination strategies, ensuring that individuals have the best possible protection.

This study, much like a scientific expedition exploring the desert landscape, investigated the immunogenicity and safety of revaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in elderly individuals. The authors meticulously analyzed data from a previous study, carefully examining the immune responses and safety profiles of individuals who received a second dose of PPSV23 after a significant time interval.

Revaccination: A Reliable Oasis

The study found that revaccination with PPSV23 at least 5 years after the initial vaccination was both immunogenic and well-tolerated in elderly individuals. This reassuring finding is like discovering a reliable oasis in the desert, providing a source of protection and reassurance.

Protecting the Elderly: A Journey Through the Desert of Age

As we age, our immune system weakens, making us more susceptible to infections. Vaccination plays a crucial role in bolstering immunity and protecting us from disease. This research reinforces the importance of staying up-to-date on vaccinations, especially for the elderly, who are more vulnerable to pneumococcal disease.

Dr.Camel's Conclusion

This study provides valuable information for healthcare providers and individuals seeking to optimize their vaccination strategies. It underscores the importance of revaccination in maintaining immunity and protecting those at higher risk of pneumococcal disease. Like a wise camel navigating the desert, we must be proactive in our health and take advantage of the tools available to protect ourselves.

Date :
  1. Date Completed 2019-04-29
  2. Date Revised 2019-04-29
Further Info :

Pubmed ID

29580133

DOI: Digital Object Identifier

PMC6149784

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.